Cargando…
Sex differences in COVID-19 mortality: opportunity to develop HSP27 (HSPB1) immunotherapy to treat hyper-inflammation?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Netherlands
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407440/ https://www.ncbi.nlm.nih.gov/pubmed/32761452 http://dx.doi.org/10.1007/s12192-020-01146-5 |
| _version_ | 1783567621235408896 |
|---|---|
| author | O’Brien, Edward R. Sandhu, Jagdeep K. |
| author_facet | O’Brien, Edward R. Sandhu, Jagdeep K. |
| author_sort | O’Brien, Edward R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7407440 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer Netherlands |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74074402020-08-06 Sex differences in COVID-19 mortality: opportunity to develop HSP27 (HSPB1) immunotherapy to treat hyper-inflammation? O’Brien, Edward R. Sandhu, Jagdeep K. Cell Stress Chaperones Letter to the Editor Springer Netherlands 2020-08-06 2020-09 /pmc/articles/PMC7407440/ /pubmed/32761452 http://dx.doi.org/10.1007/s12192-020-01146-5 Text en © Cell Stress Society International 2020 |
| spellingShingle | Letter to the Editor O’Brien, Edward R. Sandhu, Jagdeep K. Sex differences in COVID-19 mortality: opportunity to develop HSP27 (HSPB1) immunotherapy to treat hyper-inflammation? |
| title | Sex differences in COVID-19 mortality: opportunity to develop HSP27 (HSPB1) immunotherapy to treat hyper-inflammation? |
| title_full | Sex differences in COVID-19 mortality: opportunity to develop HSP27 (HSPB1) immunotherapy to treat hyper-inflammation? |
| title_fullStr | Sex differences in COVID-19 mortality: opportunity to develop HSP27 (HSPB1) immunotherapy to treat hyper-inflammation? |
| title_full_unstemmed | Sex differences in COVID-19 mortality: opportunity to develop HSP27 (HSPB1) immunotherapy to treat hyper-inflammation? |
| title_short | Sex differences in COVID-19 mortality: opportunity to develop HSP27 (HSPB1) immunotherapy to treat hyper-inflammation? |
| title_sort | sex differences in covid-19 mortality: opportunity to develop hsp27 (hspb1) immunotherapy to treat hyper-inflammation? |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407440/ https://www.ncbi.nlm.nih.gov/pubmed/32761452 http://dx.doi.org/10.1007/s12192-020-01146-5 |
| work_keys_str_mv | AT obrienedwardr sexdifferencesincovid19mortalityopportunitytodevelophsp27hspb1immunotherapytotreathyperinflammation AT sandhujagdeepk sexdifferencesincovid19mortalityopportunitytodevelophsp27hspb1immunotherapytotreathyperinflammation |